Title:Key Advances in MIP-based Sensors Applied for Cancer and Cardiovascular
Biomarkers Detection
Volume: 22
Issue: 7
Author(s): Abderrahman Lamaoui and Aziz Amine*
Affiliation:
- Laboratoire Génie des Procédés & Environnement, Faculté des Sciences et Techniques, Hassan II University of Casablanca, B.P. 146. Mohammedia, Morocco
Keywords:
Molecularly imprinted polymer, Cancer biomarkers, Cardiovascular biomarkers, Sensor, Cardiovascular disease, Antibody.
Abstract: Cancer and cardiovascular diseases have become one of the leading causes of death
worldwide. Therefore, early detection of these diseases and rapid intervention by medical staff remain
a great challenge for clinicians and healthcare providers worldwide. Cancer and cardiovascular disease
biomarkers are promising tools for early diagnosis before it becomes incurable at an advanced
stage. They also contribute to monitoring the progress of therapy and surgical treatment. Indeed, sensors
have shown great importance for detecting cancer and cardiovascular biomarkers. Sensors usually
require a recognition element for the selective detection of targets. Molecularly imprinted polymer
(MIP), as an artificial antibody, has been proposed as an alternative recognition element in sensing
fields to overcome the main drawbacks of natural antibodies. With the high need for sensors providing
results quicklyand making the early diagnosis of these diseases easier, MIP-based sensors are
attracting considerable interest recently, which will undoubtedly be increased in the future due to the
sustainability trend. The key aim of this review is to emphasize the recent applications of sensors
based on MIP for the detection of cancer and cardiovascular biomarkers and to highlight the key advances
related to MIP-based sensors. Furthermore, several key future trends about the applications of
MIP-based sensors for detecting cardiovascular and cancer biomarkers are presented.